▶ 調査レポート

静脈血栓塞栓症(VTE)装置のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Venous Thromboembolism (VTE) Devices Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。静脈血栓塞栓症(VTE)装置のグローバル市場インサイト・予測(~2028年) / Global Venous Thromboembolism (VTE) Devices Market Insights, Forecast to 2028 / QY2203B11517資料のイメージです。• レポートコード:QY2203B11517
• 出版社/出版日:QYResearch / 2022年3月
• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療装置
• 販売価格(消費税別)
  Single User¥686,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,029,000 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,372,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の静脈血栓塞栓症(VTE)装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に静脈血栓塞栓症(VTE)装置の世界市場のxxx%を占める「深部静脈血栓症(DVT)」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の静脈血栓塞栓症(VTE)装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの静脈血栓塞栓症(VTE)装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの静脈血栓塞栓症(VTE)装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

静脈血栓塞栓症(VTE)装置のグローバル主要メーカーには、ArjoHuntleigh、Armetheon、Bayer、Bio Compression Systems、Boehringer Ingelheim、Breg、Bristol-Myers Squibb、Cardinal Health、Currie Medical Specialties、Daiichi-Sankyo、Devon Medical Products、DJO、Janssen、Mego Afek AC LTD、Normatec、Pfizer、Portola Pharmaceuticals、ThermoTek USA、Zimmer Biometなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

静脈血栓塞栓症(VTE)装置市場は、種類と用途によって区分されます。世界の静脈血栓塞栓症(VTE)装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
深部静脈血栓症(DVT)、肺塞栓症(PE)、その他

【用途別セグメント】
病院、手術センター、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 静脈血栓塞栓症(VTE)装置製品概要
- 種類別市場(深部静脈血栓症(DVT)、肺塞栓症(PE)、その他)
- 用途別市場(病院、手術センター、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の静脈血栓塞栓症(VTE)装置販売量予測2017-2028
- 世界の静脈血栓塞栓症(VTE)装置売上予測2017-2028
- 静脈血栓塞栓症(VTE)装置の地域別販売量
- 静脈血栓塞栓症(VTE)装置の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別静脈血栓塞栓症(VTE)装置販売量
- 主要メーカー別静脈血栓塞栓症(VTE)装置売上
- 主要メーカー別静脈血栓塞栓症(VTE)装置価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(深部静脈血栓症(DVT)、肺塞栓症(PE)、その他)
- 静脈血栓塞栓症(VTE)装置の種類別販売量
- 静脈血栓塞栓症(VTE)装置の種類別売上
- 静脈血栓塞栓症(VTE)装置の種類別価格
・用途別市場規模(病院、手術センター、その他)
- 静脈血栓塞栓症(VTE)装置の用途別販売量
- 静脈血栓塞栓症(VTE)装置の用途別売上
- 静脈血栓塞栓症(VTE)装置の用途別価格
・北米市場
- 北米の静脈血栓塞栓症(VTE)装置市場規模(種類別、用途別)
- 主要国別の静脈血栓塞栓症(VTE)装置市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの静脈血栓塞栓症(VTE)装置市場規模(種類別、用途別)
- 主要国別の静脈血栓塞栓症(VTE)装置市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の静脈血栓塞栓症(VTE)装置市場規模(種類別、用途別)
- 主要国別の静脈血栓塞栓症(VTE)装置市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の静脈血栓塞栓症(VTE)装置市場規模(種類別、用途別)
- 主要国別の静脈血栓塞栓症(VTE)装置市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの静脈血栓塞栓症(VTE)装置市場規模(種類別、用途別)
- 主要国別の静脈血栓塞栓症(VTE)装置市場規模(トルコ、サウジアラビア)
・企業情報
ArjoHuntleigh、Armetheon、Bayer、Bio Compression Systems、Boehringer Ingelheim、Breg、Bristol-Myers Squibb、Cardinal Health、Currie Medical Specialties、Daiichi-Sankyo、Devon Medical Products、DJO、Janssen、Mego Afek AC LTD、Normatec、Pfizer、Portola Pharmaceuticals、ThermoTek USA、Zimmer Biomet
・産業チェーン及び販売チャネル分析
- 静脈血栓塞栓症(VTE)装置の産業チェーン分析
- 静脈血栓塞栓症(VTE)装置の原材料
- 静脈血栓塞栓症(VTE)装置の生産プロセス
- 静脈血栓塞栓症(VTE)装置の販売及びマーケティング
- 静脈血栓塞栓症(VTE)装置の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 静脈血栓塞栓症(VTE)装置の産業動向
- 静脈血栓塞栓症(VTE)装置のマーケットドライバー
- 静脈血栓塞栓症(VTE)装置の課題
- 静脈血栓塞栓症(VTE)装置の阻害要因
・主な調査結果

Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual
Market Analysis and Insights: Global Venous Thromboembolism (VTE) Devices Market
Due to the COVID-19 pandemic, the global Venous Thromboembolism (VTE) Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Deep Vein Thrombosis(DVT) accounting for % of the Venous Thromboembolism (VTE) Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Venous Thromboembolism (VTE) Devices market size is valued at US$ million in 2021, while the US and Europe Venous Thromboembolism (VTE) Devices are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Venous Thromboembolism (VTE) Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Venous Thromboembolism (VTE) Devices include ArjoHuntleigh, Armetheon, Bayer, Bio Compression Systems, Boehringer Ingelheim, Breg, Bristol-Myers Squibb, Cardinal Health and Currie Medical Specialties, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Venous Thromboembolism (VTE) Devices Scope and Segment
Venous Thromboembolism (VTE) Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Venous Thromboembolism (VTE) Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Deep Vein Thrombosis(DVT)
Pulmonary Embolism(PE)
Others
Segment by Application
Hospitals
Surgical Centers
Other
By Company
ArjoHuntleigh
Armetheon
Bayer
Bio Compression Systems
Boehringer Ingelheim
Breg
Bristol-Myers Squibb
Cardinal Health
Currie Medical Specialties
Daiichi-Sankyo
Devon Medical Products
DJO
Janssen
Mego Afek AC LTD
Normatec
Pfizer
Portola Pharmaceuticals
ThermoTek USA
Zimmer Biomet
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Venous Thromboembolism (VTE) Devices Product Introduction
1.2 Market by Type
1.2.1 Global Venous Thromboembolism (VTE) Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Deep Vein Thrombosis(DVT)
1.2.3 Pulmonary Embolism(PE)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Venous Thromboembolism (VTE) Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Venous Thromboembolism (VTE) Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Venous Thromboembolism (VTE) Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Venous Thromboembolism (VTE) Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Venous Thromboembolism (VTE) Devices Sales by Region
2.4.1 Global Venous Thromboembolism (VTE) Devices Sales by Region (2017-2022)
2.4.2 Global Sales Venous Thromboembolism (VTE) Devices by Region (2023-2028)
2.5 Global Venous Thromboembolism (VTE) Devices Revenue by Region
2.5.1 Global Venous Thromboembolism (VTE) Devices Revenue by Region (2017-2022)
2.5.2 Global Venous Thromboembolism (VTE) Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Venous Thromboembolism (VTE) Devices Sales by Manufacturers
3.1.1 Global Top Venous Thromboembolism (VTE) Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Venous Thromboembolism (VTE) Devices in 2021
3.2 Global Venous Thromboembolism (VTE) Devices Revenue by Manufacturers
3.2.1 Global Venous Thromboembolism (VTE) Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Venous Thromboembolism (VTE) Devices Revenue in 2021
3.3 Global Venous Thromboembolism (VTE) Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Venous Thromboembolism (VTE) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Venous Thromboembolism (VTE) Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Venous Thromboembolism (VTE) Devices Sales by Type
4.1.1 Global Venous Thromboembolism (VTE) Devices Historical Sales by Type (2017-2022)
4.1.2 Global Venous Thromboembolism (VTE) Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2017-2028)
4.2 Global Venous Thromboembolism (VTE) Devices Revenue by Type
4.2.1 Global Venous Thromboembolism (VTE) Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Venous Thromboembolism (VTE) Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2017-2028)
4.3 Global Venous Thromboembolism (VTE) Devices Price by Type
4.3.1 Global Venous Thromboembolism (VTE) Devices Price by Type (2017-2022)
4.3.2 Global Venous Thromboembolism (VTE) Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Venous Thromboembolism (VTE) Devices Sales by Application
5.1.1 Global Venous Thromboembolism (VTE) Devices Historical Sales by Application (2017-2022)
5.1.2 Global Venous Thromboembolism (VTE) Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2017-2028)
5.2 Global Venous Thromboembolism (VTE) Devices Revenue by Application
5.2.1 Global Venous Thromboembolism (VTE) Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Venous Thromboembolism (VTE) Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2017-2028)
5.3 Global Venous Thromboembolism (VTE) Devices Price by Application
5.3.1 Global Venous Thromboembolism (VTE) Devices Price by Application (2017-2022)
5.3.2 Global Venous Thromboembolism (VTE) Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Venous Thromboembolism (VTE) Devices Market Size by Type
6.1.1 North America Venous Thromboembolism (VTE) Devices Sales by Type (2017-2028)
6.1.2 North America Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2028)
6.2 North America Venous Thromboembolism (VTE) Devices Market Size by Application
6.2.1 North America Venous Thromboembolism (VTE) Devices Sales by Application (2017-2028)
6.2.2 North America Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2028)
6.3 North America Venous Thromboembolism (VTE) Devices Market Size by Country
6.3.1 North America Venous Thromboembolism (VTE) Devices Sales by Country (2017-2028)
6.3.2 North America Venous Thromboembolism (VTE) Devices Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Venous Thromboembolism (VTE) Devices Market Size by Type
7.1.1 Europe Venous Thromboembolism (VTE) Devices Sales by Type (2017-2028)
7.1.2 Europe Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2028)
7.2 Europe Venous Thromboembolism (VTE) Devices Market Size by Application
7.2.1 Europe Venous Thromboembolism (VTE) Devices Sales by Application (2017-2028)
7.2.2 Europe Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2028)
7.3 Europe Venous Thromboembolism (VTE) Devices Market Size by Country
7.3.1 Europe Venous Thromboembolism (VTE) Devices Sales by Country (2017-2028)
7.3.2 Europe Venous Thromboembolism (VTE) Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Venous Thromboembolism (VTE) Devices Market Size by Type
8.1.1 Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Venous Thromboembolism (VTE) Devices Market Size by Application
8.2.1 Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Venous Thromboembolism (VTE) Devices Market Size by Region
8.3.1 Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Venous Thromboembolism (VTE) Devices Market Size by Type
9.1.1 Latin America Venous Thromboembolism (VTE) Devices Sales by Type (2017-2028)
9.1.2 Latin America Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2028)
9.2 Latin America Venous Thromboembolism (VTE) Devices Market Size by Application
9.2.1 Latin America Venous Thromboembolism (VTE) Devices Sales by Application (2017-2028)
9.2.2 Latin America Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2028)
9.3 Latin America Venous Thromboembolism (VTE) Devices Market Size by Country
9.3.1 Latin America Venous Thromboembolism (VTE) Devices Sales by Country (2017-2028)
9.3.2 Latin America Venous Thromboembolism (VTE) Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Size by Type
10.1.1 Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Size by Application
10.2.1 Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Size by Country
10.3.1 Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ArjoHuntleigh
11.1.1 ArjoHuntleigh Corporation Information
11.1.2 ArjoHuntleigh Overview
11.1.3 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ArjoHuntleigh Recent Developments
11.2 Armetheon
11.2.1 Armetheon Corporation Information
11.2.2 Armetheon Overview
11.2.3 Armetheon Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Armetheon Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Armetheon Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 Bio Compression Systems
11.4.1 Bio Compression Systems Corporation Information
11.4.2 Bio Compression Systems Overview
11.4.3 Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bio Compression Systems Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio Compression Systems Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Overview
11.5.3 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Breg
11.6.1 Breg Corporation Information
11.6.2 Breg Overview
11.6.3 Breg Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Breg Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Breg Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Overview
11.7.3 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bristol-Myers Squibb Recent Developments
11.8 Cardinal Health
11.8.1 Cardinal Health Corporation Information
11.8.2 Cardinal Health Overview
11.8.3 Cardinal Health Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cardinal Health Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cardinal Health Recent Developments
11.9 Currie Medical Specialties
11.9.1 Currie Medical Specialties Corporation Information
11.9.2 Currie Medical Specialties Overview
11.9.3 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Currie Medical Specialties Recent Developments
11.10 Daiichi-Sankyo
11.10.1 Daiichi-Sankyo Corporation Information
11.10.2 Daiichi-Sankyo Overview
11.10.3 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Daiichi-Sankyo Recent Developments
11.11 Devon Medical Products
11.11.1 Devon Medical Products Corporation Information
11.11.2 Devon Medical Products Overview
11.11.3 Devon Medical Products Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Devon Medical Products Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Devon Medical Products Recent Developments
11.12 DJO
11.12.1 DJO Corporation Information
11.12.2 DJO Overview
11.12.3 DJO Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 DJO Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 DJO Recent Developments
11.13 Janssen
11.13.1 Janssen Corporation Information
11.13.2 Janssen Overview
11.13.3 Janssen Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Janssen Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Janssen Recent Developments
11.14 Mego Afek AC LTD
11.14.1 Mego Afek AC LTD Corporation Information
11.14.2 Mego Afek AC LTD Overview
11.14.3 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Mego Afek AC LTD Recent Developments
11.15 Normatec
11.15.1 Normatec Corporation Information
11.15.2 Normatec Overview
11.15.3 Normatec Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Normatec Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Normatec Recent Developments
11.16 Pfizer
11.16.1 Pfizer Corporation Information
11.16.2 Pfizer Overview
11.16.3 Pfizer Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Pfizer Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Pfizer Recent Developments
11.17 Portola Pharmaceuticals
11.17.1 Portola Pharmaceuticals Corporation Information
11.17.2 Portola Pharmaceuticals Overview
11.17.3 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Portola Pharmaceuticals Recent Developments
11.18 ThermoTek USA
11.18.1 ThermoTek USA Corporation Information
11.18.2 ThermoTek USA Overview
11.18.3 ThermoTek USA Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 ThermoTek USA Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 ThermoTek USA Recent Developments
11.19 Zimmer Biomet
11.19.1 Zimmer Biomet Corporation Information
11.19.2 Zimmer Biomet Overview
11.19.3 Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Zimmer Biomet Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Zimmer Biomet Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Venous Thromboembolism (VTE) Devices Industry Chain Analysis
12.2 Venous Thromboembolism (VTE) Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Venous Thromboembolism (VTE) Devices Production Mode & Process
12.4 Venous Thromboembolism (VTE) Devices Sales and Marketing
12.4.1 Venous Thromboembolism (VTE) Devices Sales Channels
12.4.2 Venous Thromboembolism (VTE) Devices Distributors
12.5 Venous Thromboembolism (VTE) Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Venous Thromboembolism (VTE) Devices Industry Trends
13.2 Venous Thromboembolism (VTE) Devices Market Drivers
13.3 Venous Thromboembolism (VTE) Devices Market Challenges
13.4 Venous Thromboembolism (VTE) Devices Market Restraints
14 Key Findings in The Global Venous Thromboembolism (VTE) Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Venous Thromboembolism (VTE) Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Deep Vein Thrombosis(DVT)
Table 3. Major Manufacturers of Pulmonary Embolism(PE)
Table 4. Major Manufacturers of Others
Table 5. Global Venous Thromboembolism (VTE) Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Venous Thromboembolism (VTE) Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Venous Thromboembolism (VTE) Devices Sales by Region (2017-2022) & (K Units)
Table 8. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Region (2017-2022)
Table 9. Global Venous Thromboembolism (VTE) Devices Sales by Region (2023-2028) & (K Units)
Table 10. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Region (2023-2028)
Table 11. Global Venous Thromboembolism (VTE) Devices Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Region (2017-2022)
Table 13. Global Venous Thromboembolism (VTE) Devices Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Region (2023-2028)
Table 15. Global Venous Thromboembolism (VTE) Devices Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Venous Thromboembolism (VTE) Devices Sales Share by Manufacturers (2017-2022)
Table 17. Global Venous Thromboembolism (VTE) Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Venous Thromboembolism (VTE) Devices Revenue Share by Manufacturers (2017-2022)
Table 19. Venous Thromboembolism (VTE) Devices Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Venous Thromboembolism (VTE) Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Venous Thromboembolism (VTE) Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism (VTE) Devices as of 2021)
Table 22. Venous Thromboembolism (VTE) Devices Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Venous Thromboembolism (VTE) Devices Product Offered
Table 24. Date of Manufacturers Enter into Venous Thromboembolism (VTE) Devices Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Venous Thromboembolism (VTE) Devices Sales by Type (2017-2022) & (K Units)
Table 27. Global Venous Thromboembolism (VTE) Devices Sales by Type (2023-2028) & (K Units)
Table 28. Global Venous Thromboembolism (VTE) Devices Sales Share by Type (2017-2022)
Table 29. Global Venous Thromboembolism (VTE) Devices Sales Share by Type (2023-2028)
Table 30. Global Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Venous Thromboembolism (VTE) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Venous Thromboembolism (VTE) Devices Revenue Share by Type (2017-2022)
Table 33. Global Venous Thromboembolism (VTE) Devices Revenue Share by Type (2023-2028)
Table 34. Venous Thromboembolism (VTE) Devices Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Venous Thromboembolism (VTE) Devices Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Venous Thromboembolism (VTE) Devices Sales by Application (2017-2022) & (K Units)
Table 37. Global Venous Thromboembolism (VTE) Devices Sales by Application (2023-2028) & (K Units)
Table 38. Global Venous Thromboembolism (VTE) Devices Sales Share by Application (2017-2022)
Table 39. Global Venous Thromboembolism (VTE) Devices Sales Share by Application (2023-2028)
Table 40. Global Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Venous Thromboembolism (VTE) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Venous Thromboembolism (VTE) Devices Revenue Share by Application (2017-2022)
Table 43. Global Venous Thromboembolism (VTE) Devices Revenue Share by Application (2023-2028)
Table 44. Venous Thromboembolism (VTE) Devices Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Venous Thromboembolism (VTE) Devices Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Venous Thromboembolism (VTE) Devices Sales by Type (2017-2022) & (K Units)
Table 47. North America Venous Thromboembolism (VTE) Devices Sales by Type (2023-2028) & (K Units)
Table 48. North America Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Venous Thromboembolism (VTE) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Venous Thromboembolism (VTE) Devices Sales by Application (2017-2022) & (K Units)
Table 51. North America Venous Thromboembolism (VTE) Devices Sales by Application (2023-2028) & (K Units)
Table 52. North America Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Venous Thromboembolism (VTE) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Venous Thromboembolism (VTE) Devices Sales by Country (2017-2022) & (K Units)
Table 55. North America Venous Thromboembolism (VTE) Devices Sales by Country (2023-2028) & (K Units)
Table 56. North America Venous Thromboembolism (VTE) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Venous Thromboembolism (VTE) Devices Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Venous Thromboembolism (VTE) Devices Sales by Type (2017-2022) & (K Units)
Table 59. Europe Venous Thromboembolism (VTE) Devices Sales by Type (2023-2028) & (K Units)
Table 60. Europe Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Venous Thromboembolism (VTE) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Venous Thromboembolism (VTE) Devices Sales by Application (2017-2022) & (K Units)
Table 63. Europe Venous Thromboembolism (VTE) Devices Sales by Application (2023-2028) & (K Units)
Table 64. Europe Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Venous Thromboembolism (VTE) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Venous Thromboembolism (VTE) Devices Sales by Country (2017-2022) & (K Units)
Table 67. Europe Venous Thromboembolism (VTE) Devices Sales by Country (2023-2028) & (K Units)
Table 68. Europe Venous Thromboembolism (VTE) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Venous Thromboembolism (VTE) Devices Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Venous Thromboembolism (VTE) Devices Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Venous Thromboembolism (VTE) Devices Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Venous Thromboembolism (VTE) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Venous Thromboembolism (VTE) Devices Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Venous Thromboembolism (VTE) Devices Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Venous Thromboembolism (VTE) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Venous Thromboembolism (VTE) Devices Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Venous Thromboembolism (VTE) Devices Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Venous Thromboembolism (VTE) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Venous Thromboembolism (VTE) Devices Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Country (2023-2028) & (US$ Million)
Table 106. ArjoHuntleigh Corporation Information
Table 107. ArjoHuntleigh Description and Major Businesses
Table 108. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. ArjoHuntleigh Recent Developments
Table 111. Armetheon Corporation Information
Table 112. Armetheon Description and Major Businesses
Table 113. Armetheon Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Armetheon Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Armetheon Recent Developments
Table 116. Bayer Corporation Information
Table 117. Bayer Description and Major Businesses
Table 118. Bayer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Bayer Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Bayer Recent Developments
Table 121. Bio Compression Systems Corporation Information
Table 122. Bio Compression Systems Description and Major Businesses
Table 123. Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Bio Compression Systems Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Bio Compression Systems Recent Developments
Table 126. Boehringer Ingelheim Corporation Information
Table 127. Boehringer Ingelheim Description and Major Businesses
Table 128. Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Boehringer Ingelheim Recent Developments
Table 131. Breg Corporation Information
Table 132. Breg Description and Major Businesses
Table 133. Breg Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Breg Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Breg Recent Developments
Table 136. Bristol-Myers Squibb Corporation Information
Table 137. Bristol-Myers Squibb Description and Major Businesses
Table 138. Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Bristol-Myers Squibb Recent Developments
Table 141. Cardinal Health Corporation Information
Table 142. Cardinal Health Description and Major Businesses
Table 143. Cardinal Health Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Cardinal Health Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Cardinal Health Recent Developments
Table 146. Currie Medical Specialties Corporation Information
Table 147. Currie Medical Specialties Description and Major Businesses
Table 148. Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Currie Medical Specialties Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Currie Medical Specialties Recent Developments
Table 151. Daiichi-Sankyo Corporation Information
Table 152. Daiichi-Sankyo Description and Major Businesses
Table 153. Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Daiichi-Sankyo Recent Developments
Table 156. Devon Medical Products Corporation Information
Table 157. Devon Medical Products Description and Major Businesses
Table 158. Devon Medical Products Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Devon Medical Products Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Devon Medical Products Recent Developments
Table 161. DJO Corporation Information
Table 162. DJO Description and Major Businesses
Table 163. DJO Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. DJO Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. DJO Recent Developments
Table 166. Janssen Corporation Information
Table 167. Janssen Description and Major Businesses
Table 168. Janssen Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. Janssen Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Janssen Recent Developments
Table 171. Mego Afek AC LTD Corporation Information
Table 172. Mego Afek AC LTD Description and Major Businesses
Table 173. Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 174. Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Mego Afek AC LTD Recent Developments
Table 176. Normatec Corporation Information
Table 177. Normatec Description and Major Businesses
Table 178. Normatec Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 179. Normatec Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Normatec Recent Developments
Table 181. Pfizer Corporation Information
Table 182. Pfizer Description and Major Businesses
Table 183. Pfizer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 184. Pfizer Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Pfizer Recent Developments
Table 186. Portola Pharmaceuticals Corporation Information
Table 187. Portola Pharmaceuticals Description and Major Businesses
Table 188. Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 189. Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 190. Portola Pharmaceuticals Recent Developments
Table 191. ThermoTek USA Corporation Information
Table 192. ThermoTek USA Description and Major Businesses
Table 193. ThermoTek USA Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 194. ThermoTek USA Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 195. ThermoTek USA Recent Developments
Table 196. Zimmer Biomet Corporation Information
Table 197. Zimmer Biomet Description and Major Businesses
Table 198. Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 199. Zimmer Biomet Venous Thromboembolism (VTE) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 200. Zimmer Biomet Recent Developments
Table 201. Key Raw Materials Lists
Table 202. Raw Materials Key Suppliers Lists
Table 203. Venous Thromboembolism (VTE) Devices Distributors List
Table 204. Venous Thromboembolism (VTE) Devices Customers List
Table 205. Venous Thromboembolism (VTE) Devices Market Trends
Table 206. Venous Thromboembolism (VTE) Devices Market Drivers
Table 207. Venous Thromboembolism (VTE) Devices Market Challenges
Table 208. Venous Thromboembolism (VTE) Devices Market Restraints
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources
List of Figures
Figure 1. Venous Thromboembolism (VTE) Devices Product Picture
Figure 3. Global Venous Thromboembolism (VTE) Devices Market Share by Type in 2021 & 2028
Figure 3. Deep Vein Thrombosis(DVT) Product Picture
Figure 4. Pulmonary Embolism(PE) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Venous Thromboembolism (VTE) Devices Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Surgical Centers
Figure 9. Other
Figure 10. Venous Thromboembolism (VTE) Devices Report Years Considered
Figure 11. Global Venous Thromboembolism (VTE) Devices Sales 2017-2028 (K Units)
Figure 12. Global Venous Thromboembolism (VTE) Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Venous Thromboembolism (VTE) Devices Revenue 2017-2028 (US$ Million)
Figure 14. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Region (2017-2022)
Figure 16. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Region (2023-2028)
Figure 17. North America Venous Thromboembolism (VTE) Devices Sales YoY (2017-2028) & (K Units)
Figure 18. North America Venous Thromboembolism (VTE) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Venous Thromboembolism (VTE) Devices Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Venous Thromboembolism (VTE) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Venous Thromboembolism (VTE) Devices Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Venous Thromboembolism (VTE) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Venous Thromboembolism (VTE) Devices Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Venous Thromboembolism (VTE) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Venous Thromboembolism (VTE) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Venous Thromboembolism (VTE) Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Venous Thromboembolism (VTE) Devices in the World: Market Share by Venous Thromboembolism (VTE) Devices Revenue in 2021
Figure 29. Global Venous Thromboembolism (VTE) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2017-2028)
Figure 31. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2017-2028)
Figure 32. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2017-2028)
Figure 33. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2017-2028)
Figure 34. North America Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2017-2028)
Figure 35. North America Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2017-2028)
Figure 36. North America Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2017-2028)
Figure 37. North America Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2017-2028)
Figure 38. North America Venous Thromboembolism (VTE) Devices Sales Share by Country (2017-2028)
Figure 39. North America Venous Thromboembolism (VTE) Devices Revenue Share by Country (2017-2028)
Figure 40. U.S. Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2017-2028)
Figure 43. Europe Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2017-2028)
Figure 44. Europe Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2017-2028)
Figure 45. Europe Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2017-2028)
Figure 46. Europe Venous Thromboembolism (VTE) Devices Sales Share by Country (2017-2028)
Figure 47. Europe Venous Thromboembolism (VTE) Devices Revenue Share by Country (2017-2028)
Figure 48. Germany Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 49. France Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Venous Thromboembolism (VTE) Devices Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue Share by Region (2017-2028)
Figure 59. China Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 62. India Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2017-2028)
Figure 70. Latin America Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2017-2028)
Figure 72. Latin America Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Venous Thromboembolism (VTE) Devices Sales Share by Country (2017-2028)
Figure 74. Latin America Venous Thromboembolism (VTE) Devices Revenue Share by Country (2017-2028)
Figure 75. Mexico Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue Share by Country (2017-2028)
Figure 84. Turkey Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Venous Thromboembolism (VTE) Devices Revenue (2017-2028) & (US$ Million)
Figure 87. Venous Thromboembolism (VTE) Devices Value Chain
Figure 88. Venous Thromboembolism (VTE) Devices Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed